past Attendees at our event
Alzchem Group
AstraZeneca
Biological E Limited
BioNTech SE
CureVac SE
DIANA Biotechnologies
Imperial College London
Oxford Nanopore
Sartorius BIA Separations
TriLink Biotechnologies
UCB
WuXi AppTec
topics on the agenda
ESTABLISHING AN “RNA COOPERATIVE” TO CO-DEVELOP AN mRNA VACCINE
Day 1: WEDNESDAY, 22 JULY, 2026
09:00 - 09:25
NOVEL APPROACH TO IDENTIFY BIOMARKERS FOR mRNA-BASED THERAPEUTICS AND VACCINES
Day 1: WEDNESDAY, 22 JULY, 2026
09:30 - 09:55
ENABLING RAPID mRNA VACCINE DEVELOPMENT WITH CELL-FREE DNA TEMPLATES FOR PANDEMIC PREPAREDNESS
Day 1: WEDNESDAY, 22 JULY, 2026
10:00 - 10:25
Meet the Leaders
Alzchem Group AG
AstraZeneca
Biological E Limited
BioNTech SE
CureVac SE
GlaxoSmithKline
Johnson & Johnson MedTech
Merck
Novartis
Novo Nordisk
Oxford Nanopore
Pfizer
Recipharm
Roche
Sanofi
UCB
WuXi AppTec
Zealand Pharma
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.